Novo-Nordisk A/SNovo-Nordisk A/SNovo-Nordisk A/S

Novo-Nordisk A/S

No trades
See on Supercharts
Market capitalization
‪549.90 B‬USD
‪12.39 B‬USD
‪34.38 B‬USD
‪3.15 B‬
Beta (1Y)
1.50

About Novo-Nordisk A/S

CEO
Lars Fruergaard Jørgensen
Headquarters
Bagsværd
Employees (FY)
‪63.37 K‬
Founded
1931
ISIN
DK0062498333
FIGI
BBG000K139Z3
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of NONOF is 122.50 USD — it has decreased by 0.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Novo-Nordisk A/S stocks are traded under the ticker NONOF.
Novo-Nordisk A/S is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
NONOF stock is 2.42% volatile and has beta coefficient of 1.50. Check out the list of the most volatile stocks — is Novo-Nordisk A/S there?
One year price forecast for Novo-Nordisk A/S has a max estimate of 162.42 USD and a min estimate of 75.42 USD.
NONOF earnings for the last quarter are 0.71 USD per share, whereas the estimation was 0.68 USD resulting in a 4.02% surprise. The estimated earnings for the next quarter are 0.68 USD per share. See more details about Novo-Nordisk A/S earnings.
Novo-Nordisk A/S revenue for the last quarter amounts to ‪8.30 B‬ USD despite the estimated figure of ‪8.17 B‬ USD. In the next quarter revenue is expected to reach ‪9.27 B‬ USD.
Yes, you can track Novo-Nordisk A/S financials in yearly and quarterly reports right on TradingView.
NONOF stock has fallen by 6.17% compared to the previous week, the month change is a 7.86% fall, over the last year Novo-Nordisk A/S has showed a 50.00% increase.
NONOF net income for the last quarter is ‪3.25 B‬ USD, while the quarter before that showed ‪3.18 B‬ USD of net income which accounts for 2.29% change. Track more Novo-Nordisk A/S financial stats to get the full picture.
Today Novo-Nordisk A/S has the market capitalization of ‪547.31 B‬, it has increased by 1.36% over the last week.
Novo-Nordisk A/S dividend yield was 1.35% in 2023, and payout ratio reached 50.35%. The year before the numbers were 1.32% and 50.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NONOF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novo-Nordisk A/S stock right from TradingView charts — choose your broker and connect to your account.
NONOF reached its all-time high on Mar 7, 2024 with the price of 140.32 USD, and its all-time low was 15.54 USD and was reached on Nov 23, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has ‪63.37 K‬ employees. See our rating of the largest employees — is Novo-Nordisk A/S on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novo-Nordisk A/S technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novo-Nordisk A/S stock shows the buy signal. See more of Novo-Nordisk A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Novo-Nordisk A/S future price: according to them, NONOF price has a max estimate of 162.42 USD and a min estimate of 75.42 USD. Read a more detailed Novo-Nordisk A/S forecast: see what analysts think of Novo-Nordisk A/S and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Novo-Nordisk A/S EBITDA is ‪16.56 B‬ USD, and current EBITDA margin is 47.96%. See more stats in Novo-Nordisk A/S financial statements.